Covered recipient · General Payments record
THERESA A EBLIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,106.43
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $182.80 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $35.98 | 2 |
| Acerta Pharma LLC | $35.04 | 2 |
| Lilly USA, LLC | $27.30 | 2 |
| Inspire Medical Systems, Inc. | $23.58 | 1 |
| PFIZER INC. | $16.29 | 1 |
| Novo Nordisk AS | $16.10 | 1 |
| SANOFI-AVENTIS U.S. LLC | $14.75 | 1 |
| Currax Pharmaceuticals LLC | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.62 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107058236 | CMS |
| ABBVIE INC. | $18.36 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107058238 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.36 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105856524 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.68 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105734857 | CMS |
| Currax Pharmaceuticals LLC | $13.76 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089525607 | CMS |
| Inspire Medical Systems, Inc. | $23.58 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148146966 | CMS |
| Lilly USA, LLC | $14.08 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135968708 | CMS |
| Lilly USA, LLC | $13.22 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135968710 | CMS |
| Novo Nordisk Inc | $16.10 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100514131 | CMS |
| PFIZER INC. | $16.29 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131492346 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.75 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139674366 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.